BHVN logo

Biohaven Pharmaceutical Holding (BHVN) Shareholders Equity

Annual Shareholders Equity

$427.98 M
-$110.80 M-20.56%

31 December 2023

BHVN Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$316.01 M
-$67.73 M-17.65%

30 September 2024

BHVN Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BHVN Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-20.6%+9.0%
3 y3 years+2450.3%+810.9%
5 y5 years+183.6%+4356.6%

BHVN Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-20.6%+2450.3%-41.4%+810.9%
5 y5 years-20.6%+5864.8%-41.4%+180.9%
alltimeall time-20.6%+1050.4%-41.4%+180.9%

Biohaven Pharmaceutical Holding Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$316.01 M(-17.7%)
June 2024
-
$383.74 M(+27.3%)
Mar 2024
-
$301.45 M(-29.6%)
Dec 2023
$427.98 M(-20.6%)
$427.98 M(+47.6%)
Sept 2023
-
$290.01 M(-25.1%)
June 2023
-
$387.25 M(-18.0%)
Mar 2023
-
$472.26 M(-12.3%)
Dec 2022
$538.77 M(+1453.1%)
$538.77 M(+437.6%)
Sept 2022
-
$100.22 M(-61.8%)
June 2022
-
$262.23 M(+655.9%)
Dec 2021
$34.69 M(+106.7%)
-
Dec 2021
-
$34.69 M(-108.9%)
Dec 2020
$16.78 M(-326.0%)
-
Dec 2020
-
-$390.37 M(+83.8%)
Sept 2020
-
-$212.38 M(+498.8%)
June 2020
-
-$35.47 M(-129.1%)
Mar 2020
-
$121.96 M
DateAnnualQuarterly
Dec 2019
-$7.42 M(-104.9%)
-
Dec 2019
-
-$7.42 M(-106.2%)
Sept 2019
-
$118.98 M(-36.3%)
June 2019
-
$186.74 M(+92.5%)
Mar 2019
-
$97.01 M(-35.7%)
Dec 2018
$150.92 M(+14.4%)
-
Dec 2018
-
$150.92 M(+129.3%)
Sept 2018
-
$65.81 M(-44.6%)
June 2018
-
$118.83 M(+10.2%)
Mar 2018
-
$107.82 M(-18.3%)
Dec 2017
$131.97 M(-393.1%)
-
Dec 2017
-
$131.97 M(-15.5%)
Sept 2017
-
$156.19 M(-19.0%)
June 2017
-
$192.85 M(-460.2%)
Mar 2017
-
-$53.54 M(+18.9%)
Dec 2016
-$45.03 M(-4036.5%)
-
Dec 2016
-
-$45.03 M
Dec 2015
$1.14 M
-

FAQ

  • What is Biohaven Pharmaceutical Holding annual stockholders equity?
  • What is the all time high annual shareholders equity for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding annual shareholders equity year-on-year change?
  • What is Biohaven Pharmaceutical Holding quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding quarterly shareholders equity year-on-year change?

What is Biohaven Pharmaceutical Holding annual stockholders equity?

The current annual shareholders equity of BHVN is $427.98 M

What is the all time high annual shareholders equity for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high annual stockholders equity is $538.77 M

What is Biohaven Pharmaceutical Holding annual shareholders equity year-on-year change?

Over the past year, BHVN annual stockholders equity has changed by -$110.80 M (-20.56%)

What is Biohaven Pharmaceutical Holding quarterly stockholders equity?

The current quarterly shareholders equity of BHVN is $316.01 M

What is the all time high quarterly shareholders equity for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high quarterly stockholders equity is $538.77 M

What is Biohaven Pharmaceutical Holding quarterly shareholders equity year-on-year change?

Over the past year, BHVN quarterly stockholders equity has changed by +$26.00 M (+8.97%)